EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden

Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli Hemminki, Rudolf Kaaks, Kari Hemminki iD

Annals of Translational Medicine · 2026-06 · 14 (3) · 31-31

DOI: 10.21037/atm-2026-0046 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Translational Medicine, 2026-06. Verfasst von Frantisek Zitricky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AdenocarcinomaT stageincidence trendlepidic subtypesurvival

Autor:innen und Institutionen

  • Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
  • Center for Primary Health Care Research, Lund University, Malmö, Sweden.
  • University Clinic Primary Care Skåne, Region Skåne, Sweden.
  • Department of Family and Community Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA.
  • Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

ORCID-Profile: Kari Hemminki

Zitieren

APA

Zitricky, F., Sundquist, K., Sundquist, J., Försti, A., Hemminki, A., Kaaks, R., & Hemminki, K. (2026). Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden. Annals of Translational Medicine, 14(3), 31-31. https://doi.org/10.21037/atm-2026-0046

Vancouver

Zitricky F, Sundquist K, Sundquist J, Försti A, Hemminki A, Kaaks R, et al. Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden. Annals of Translational Medicine. 2026;14(3):31-31. doi:10.21037/atm-2026-0046

BibTeX
@article{Zitricky2026,
  author = {Zitricky, Frantisek and Sundquist, Kristina and Sundquist, Jan and Försti, Asta and Hemminki, Akseli and Kaaks, Rudolf and Hemminki, Kari},
  title = {Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden},
  journal = {Annals of Translational Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {31--31},
  doi = {10.21037/atm-2026-0046}
}
Kostenlos starten →